Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 39: 380-385, 1993;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Gennip, A. H.
Right arrow Articles by Abeling, N. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Gennip, A. H.
Right arrow Articles by Abeling, N. G.

Clinical Chemistry, Vol 39, 380-385, Copyright © 1993 by American Association for Clinical Chemistry

Application of simple chromatographic methods for the diagnosis of defects in pyrimidine degradation

AH van Gennip, S Busch, L Elzinga, AE Stroomer, A van Cruchten, EG Scholten and NG Abeling
Academic Medical Center, Division of Pediatrics, Amsterdam, The Netherlands.

Recent findings suggest that inborn errors of pyrimidine catabolism are less rare than generally assumed. We propose a complete set of diagnostic methods for these disorders, suitable for the clinical chemistry laboratory, and present relevant reference data. Applications of thin-layer chromatography, high-performance liquid chromatography, and conventional cation-exchange amino acid analysis lead to detection of various defects in pyrimidine degradation, including the recently described deficiencies of dihydropyrimidine dehydrogenase and dihydropyrimidinase. We also illustrate the potential of the methods to analyze for the catabolites expected to be increased in the urine of patients with ureidopropionase deficiency. Possible pitfalls in the diagnosis and ways to prevent misdiagnosis are demonstrated. The methods offer possibilities for clinical chemistry laboratories to extend their diagnostic capacity to the new area of pyrimidine degradation defects.


The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Cancer Res.Home page
A. B. P. van Kuilenburg, E. W. Muller, J. Haasjes, R. Meinsma, L. Zoetekouw, H. R. Waterham, F. Baas, D. J. Richel, and A. H. van Gennip
Lethal Outcome of a Patient with a Complete Dihydropyrimidine Dehydrogenase (DPD) Deficiency after Administration of 5-Fluorouracil: Frequency of the Common IVS14+1G>A Mutation Causing DPD Deficiency
Clin. Cancer Res., May 1, 2001; 7(5): 1149 - 1153.
[Abstract] [Full Text]

Home page
 Clin. Chem.Home page
H. van Lenthe, A. B.P. van Kuilenburg, T. Ito, A. H. Bootsma, A. van Cruchten, Y. Wada, and A. H. van Gennip
Defects in Pyrimidine Degradation Identified by HPLC-Electrospray Tandem Mass Spectrometry of Urine Specimens or Urine-soaked Filter Paper Strips
Clin. Chem., December 1, 2000; 46(12): 1916 - 1922.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
T. Ito, A. B.P. van Kuilenburg, A. H. Bootsma, A. J. Haasnoot, A. van Cruchten, Y. Wada, and A. H. van Gennip
Rapid Screening of High-Risk Patients for Disorders of Purine and Pyrimidine Metabolism Using HPLC-Electrospray Tandem Mass Spectrometry of Liquid Urine or Urine-soaked Filter Paper Strips
Clin. Chem., April 1, 2000; 46(4): 445 - 452.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. B.P. Van Kuilenburg, H. Van Lenthe, A. Tromp, P. C.J. Veltman, and A. H. Van Gennip
Pitfalls in the Diagnosis of Patients with a Partial Dihydropyrimidine Dehydrogenase Deficiency
Clin. Chem., January 1, 2000; 46(1): 9 - 17.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
F. Y. Ahmed, S. J. Johnston, J. Cassidy, T. O'Kelly, N. Binnie, G. I. Murray, A. H. van Gennip, N. G.G.M. Abeling, S. Knight, and H. L. McLeod
Eniluracil Treatment Completely Inactivates Dihydropyrimidine Dehydrogenase in Colorectal Tumors
J. Clin. Oncol., August 1, 1999; 17(8): 2439 - 2439.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. A. Wevers, U. F.H. Engelke, S. H. Moolenaar, C. Brautigam, J. G.N. de Jong, R. Duran, R. A. de Abreu, and A. H. van Gennip
1H-NMR Spectroscopy of Body Fluids: Inborn Errors of Purine and Pyrimidine Metabolism
Clin. Chem., April 1, 1999; 45(4): 539 - 548.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Association for Clinical Chemistry.